157 related articles for article (PubMed ID: 31199431)
41. Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.
Dafopoulou K; Xavier BB; Hotterbeekx A; Janssens L; Lammens C; Dé E; Goossens H; Tsakris A; Malhotra-Kumar S; Pournaras S
Antimicrob Agents Chemother; 2015 Dec; 60(3):1892-5. PubMed ID: 26666921
[TBL] [Abstract][Full Text] [Related]
42. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
[TBL] [Abstract][Full Text] [Related]
43. Insertion sequences and sequence types profile of clinical isolates of carbapenem-resistant A. baumannii collected across India over four year period.
Vijayakumar S; Anandan S; Ms DP; Kanthan K; Vijayabaskar S; Kapil A; Ray P; Sistla S; Bhattacharya S; Wattal C; Thirunarayan ; Deotale V; Mathur P; Walia K; Ohri VC; Veeraraghavan B
J Infect Public Health; 2020 Jul; 13(7):1022-1028. PubMed ID: 31874816
[TBL] [Abstract][Full Text] [Related]
44. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
[TBL] [Abstract][Full Text] [Related]
46. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
47. Colistin Dependence in Extensively Drug-Resistant
Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
[TBL] [Abstract][Full Text] [Related]
48. Colistin-phage combinations decrease antibiotic resistance in
Wang X; Loh B; Gordillo Altamirano F; Yu Y; Hua X; Leptihn S
Emerg Microbes Infect; 2021 Dec; 10(1):2205-2219. PubMed ID: 34736365
[TBL] [Abstract][Full Text] [Related]
49. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.
Adams MD; Nickel GC; Bajaksouzian S; Lavender H; Murthy AR; Jacobs MR; Bonomo RA
Antimicrob Agents Chemother; 2009 Sep; 53(9):3628-34. PubMed ID: 19528270
[TBL] [Abstract][Full Text] [Related]
50. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
[TBL] [Abstract][Full Text] [Related]
51. Retained colistin susceptibility in clinical
Zafer MM; Hussein AFA; Al-Agamy MH; Radwan HH; Hamed SM
Front Cell Infect Microbiol; 2023; 13():1229473. PubMed ID: 37600939
[TBL] [Abstract][Full Text] [Related]
52. Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii.
Mustapha MM; Li B; Pacey MP; Mettus RT; McElheny CL; Marshall CW; Ernst RK; Cooper VS; Doi Y
J Antimicrob Chemother; 2018 Nov; 73(11):2952-2959. PubMed ID: 30124845
[TBL] [Abstract][Full Text] [Related]
53. Colistin Resistance in
Hua X; Liu L; Fang Y; Shi Q; Li X; Chen Q; Shi K; Jiang Y; Zhou H; Yu Y
Front Cell Infect Microbiol; 2017; 7():45. PubMed ID: 28275586
[No Abstract] [Full Text] [Related]
54. In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment.
Kim Y; Bae IK; Lee H; Jeong SH; Yong D; Lee K
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):362-6. PubMed ID: 24809861
[TBL] [Abstract][Full Text] [Related]
55. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI
Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642
[TBL] [Abstract][Full Text] [Related]
56. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
57. Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment.
Snitkin ES; Zelazny AM; Gupta J; ; Palmore TN; Murray PR; Segre JA
Genome Res; 2013 Jul; 23(7):1155-62. PubMed ID: 23564252
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates.
Germ J; Poirel L; Kisek TC; Spik VC; Seme K; Premru MM; Zupanc TL; Nordmann P; Pirs M
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2159-2162. PubMed ID: 31372908
[TBL] [Abstract][Full Text] [Related]
59.
Jones CL; Singh SS; Alamneh Y; Casella LG; Ernst RK; Lesho EP; Waterman PE; Zurawski DV
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993849
[TBL] [Abstract][Full Text] [Related]
60.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
